Increased vulnerability of the blood-brain barrier to acute hypertension following depletion of brain noradrenaline. 1982

E Ben-Menachem, and B B Johansson, and T H Svensson

Noradrenergic nerve terminals emanating from the pontine nucleus locus coeruleus (LC) have been suggested to take part in the regulation of intracerebral microvascular tone and, hence, blood flow. Since the extent of the blood-brain barrier opening caused by an acute hypertensive reaction previously has been shown to be highly dependent on the pre-existing cerebrovascular tone, we have explored whether selective depletion of brain noradrenaline (NA) would modify the albumin leakage caused by a hypertensive insult in the rat. Brain NA was largely and relatively selectively depleted, particularly in area innervated by the LC, by pretreatment with an injection of 6-hydroxydopamine (6-OHDA, 200 microgram) into the right lateral ventricle 7 days before the induction of an acute hypertensive reaction by intravenously administered angiotensin or adrenaline in conscious, unrestrained rats with indwelling catheters in the aorta and a jugular vein. 6-OHDA pretreatment significantly increased the leakage of 125 I-labelled albumin into the cortex after angiotensin-induced hypertension. A slight non-significant enhancement of protein in extravasation was observed after adrenaline administration. The latter substance caused, however, by itself a larger protein leakage probably related to betareceptor mediated vasodilatation. Whereas the increased permeability induced by adrenaline normally is reduced during the night, the albumin leakage was significantly increased in cortical regions in 6-OHDA treated rats in nocturnal experiments. The enhance protein leakage was not seen in rats treated with desmethylimipramine to prevent the uptake of 6-OHDA into the NA neurons.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D006892 Hydroxydopamines Dopamines with a hydroxy group substituted in one or more positions. Hydroxydopamine
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine
D016627 Oxidopamine A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals. 6-Hydroxydopamine,6-OHDA,Oxidopamine Hydrobromide,Oxidopamine Hydrochloride,6 Hydroxydopamine,Hydrobromide, Oxidopamine,Hydrochloride, Oxidopamine

Related Publications

E Ben-Menachem, and B B Johansson, and T H Svensson
October 1979, Acta neurologica Scandinavica,
E Ben-Menachem, and B B Johansson, and T H Svensson
April 1983, Acta physiologica Scandinavica,
E Ben-Menachem, and B B Johansson, and T H Svensson
October 1979, Acta neurologica Scandinavica,
E Ben-Menachem, and B B Johansson, and T H Svensson
September 1976, Experimental neurology,
E Ben-Menachem, and B B Johansson, and T H Svensson
August 2013, Neurobiology of aging,
E Ben-Menachem, and B B Johansson, and T H Svensson
January 1984, Hypertension (Dallas, Tex. : 1979),
E Ben-Menachem, and B B Johansson, and T H Svensson
November 1977, Acta physiologica Scandinavica,
E Ben-Menachem, and B B Johansson, and T H Svensson
January 1980, Advances in experimental medicine and biology,
E Ben-Menachem, and B B Johansson, and T H Svensson
January 1983, Acta medica Scandinavica. Supplementum,
Copied contents to your clipboard!